Skip to main content
PMC home page
Gut logoLink to Gut
. 1979 Nov;20(11):1012–1019. doi: 10.1136/gut.20.11.1012

Clq metabolism in ulcerative colitis and Crohn's disease.

B J Potter, H J Hodgson, A S Mee, D P Jewell
PMCID: PMC1412679  PMID: 527870

Abstract

The metabolism of pure radioiodine labelled Clq has been observed in five patients with ulcerative colitis, five patients with Crohn's disease, and in five control subjects. Both the fractional catabolic rate and the synthesis rate of Clq were increased in the five patients with Crohn's disease and in four of the five patients with ulcerative colitis. The fifth patient was in remission and had a normal synthesis rate. These results support the hypothesis that complement activation plays a role in the pathogenesis of these disease states and that the increased complement activation is primarily via the classical pathway.

Full text

PDF
1019

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Britten R. J., Roberts R. B. High-Resolution Density Gradient Sedimentation Analysis. Science. 1960 Jan 1;131(3392):32–33. doi: 10.1126/science.131.3392.32. [DOI] [PubMed] [Google Scholar]
  2. De Dombal F. T., Burton I. L., Clamp S. E., Goligher J. C. Short-term course and prognosis of Crohn's disease. Gut. 1974 Jun;15(6):435–443. doi: 10.1136/gut.15.6.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Doe W. F., Booth C. C., Brown D. L. Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis. Lancet. 1973 Feb 24;1(7800):402–403. doi: 10.1016/s0140-6736(73)90254-7. [DOI] [PubMed] [Google Scholar]
  4. Doumas B. T., Watson W. A., Biggs H. G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 1971 Jan;31(1):87–96. doi: 10.1016/0009-8981(71)90365-2. [DOI] [PubMed] [Google Scholar]
  5. Ezer G., Hayward A. R. Inhibition of complement-dependent lymphocyte rosette formation: a possible test for activated complement products. Eur J Immunol. 1974 Feb;4(2):148–150. doi: 10.1002/eji.1830040216. [DOI] [PubMed] [Google Scholar]
  6. Hodgson H. J., Potter B. J., Jewell D. P. Humoral immune system in inflammatory bowel disease: I. Complement levels. Gut. 1977 Sep;18(9):749–753. doi: 10.1136/gut.18.9.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hodgson H. J., Potter B. J., Jewell D. P. Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1977 Aug;29(2):187–196. [PMC free article] [PubMed] [Google Scholar]
  8. Hodgson H. J., Potter B. J., Skinner J., Jewell D. P. Immune-complex mediated colitis in rabbits. An experimental model. Gut. 1978 Mar;19(3):225–232. doi: 10.1136/gut.19.3.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jewell D. P., MacLennan I. C. Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol. 1973 Jun;14(2):219–226. [PMC free article] [PubMed] [Google Scholar]
  10. Kohler P. F., Müller-Eberhard H. J. Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus. J Clin Invest. 1972 Apr;51(4):868–875. doi: 10.1172/JCI106881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MATTHEWS C. M. The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol. 1957 Jul;2(1):36–53. doi: 10.1088/0031-9155/2/1/305. [DOI] [PubMed] [Google Scholar]
  12. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  13. McClelland D. B., Shearman D. J., Lai A Fat R. F., van Furth R. In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. II. Pathological tissues. Clin Exp Immunol. 1976 Jan;23(1):20–27. [PMC free article] [PubMed] [Google Scholar]
  14. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  15. Monteiro E., Fossey J., Shiner M., Drasar B. S., Allison A. C. Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet. 1971 Feb 6;1(7693):249–250. doi: 10.1016/s0140-6736(71)90997-4. [DOI] [PubMed] [Google Scholar]
  16. Mowbray J. F., Hoffbrand A. V., Holborow E. J., Seah P. P., Fry L. Circulating immune complexes in dermatitis herpetiformis. Lancet. 1973 Feb 24;1(7800):400–402. doi: 10.1016/s0140-6736(73)90253-5. [DOI] [PubMed] [Google Scholar]
  17. Reid K. B., Lowe D. M., Porter R. R. Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera. Biochem J. 1972 Dec;130(3):749–763. doi: 10.1042/bj1300749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ward M., Eastwood M. A. Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease. Gut. 1974 Oct;15(10):835–835. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES